Mrs. Shanna Gail Dudash, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 1108 Indiana Ave, La Porte, IN 46350 Phone: 219-362-5433 Fax: 219-362-0027 |
Dr. Matthew Blackmon, DC Chiropractor Medicare: Medicare Enrolled Practice Location: 204 Legacy Plz W, La Porte, IN 46350 Phone: 219-476-7246 Fax: 219-476-1713 |
Grant Chiropractic Clinic, Inc Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 451 Pine Lake Ave, La Porte, IN 46350 Phone: 219-362-3766 Fax: 219-325-8715 |
Dr. Mark Charles Grant Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 451 Pine Lake Ave, La Porte, IN 46350 Phone: 219-362-3766 |
Dr. Timothy Joseph Gurrola, D.C. Chiropractor - Internist Medicare: Not Enrolled in Medicare Practice Location: 1405 E Lincolnway, Suite A, La Porte, IN 46350 Phone: 219-325-3069 Fax: 219-362-0015 |
Rassel Family Chiropractic Center Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 1108 Indiana Ave, La Porte, IN 46350 Phone: 219-362-5433 |
Clark's Family Chiropractic, Llc Chiropractor Medicare: Medicare Enrolled Practice Location: 6646 W Johnson Rd, La Porte, IN 46350 Phone: 866-932-9630 |
Mrs. Sandra A Clark, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 6646 W Johnson Rd, La Porte, IN 46350 Phone: 866-932-9630 |
Back To Health Wellness Center, P.c, Chiropractor Medicare: Medicare Enrolled Practice Location: 2504 Monroe St, La Porte, IN 46350 Phone: 219-326-5100 Fax: 219-326-0180 |
News Archive
Nipple-sparing mastectomy is gaining ground as a treatment or preventive measure for breast cancer, given the understandable desire among patients to preserve natural appearance as much as possible. But the precise risk of preserving the nipple is not known as the cancer can spread along mammary ducts and to the nipple.
Chances are that your children will turn out OK even though they spend hours playing video games or watching TV.
Amgen Inc. today announced the submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for denosumab, a subcutaneous RANK Ligand inhibitor. The BLA submission summarizes clinical experience from nearly 6,900 patients across 18 clinical studies, including approximately 5,700 patients with advanced cancer in the three, pivotal, Phase 3, head-to-head trials versus Zometa® (zoledronic acid).
A major UK clinical trial led by Queen's University Belfast has shown how a new approach to reduce the use of mechanical ventilation can greatly improve outcomes for critically ill infants and children.
Peptimmune, Inc., a privately held biotechnology company, announced the completion of a clinical trial to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of PI-2301 in subjects with Secondary Progressive Multiple Sclerosis (SP-MS). PI-2301 is a novel peptide copolymer for the treatment of multiple sclerosis and other autoimmune diseases.
› Verified 8 days ago